Corvus Pharmaceuticals
CRVS
CRVS
42 hedge funds and large institutions have $18.1M invested in Corvus Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 10 closing their positions.
Holders
42
Holders Change
-5
Holders Change %
-10.64%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
14
Closed
10
Calls
$23K
Puts
$31K
Net Calls
-$8K
Net Calls Change
-$18K
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$1.62M |
| 2 |
2
Renaissance Technologies
New York
|
$551K |
| 3 |
3
Two Sigma Advisers
New York
|
$221K |
| 4 |
4
Two Sigma Investments
New York
|
$239K |
| 5 |
TI
5
Telemetry Investments
New York
|
$332K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SPIA
51
Steward Partners Investment Advisory
New York
| – | – | -25 | Closed |
|
52
Barclays
London,
United Kingdom
| $0 | 1 | – | – |
|
|
CFGS
53
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|